Company / Cash & Equivalents
Globus Medical Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$526.2M
FY2025
5-year range
$526.2M / $784.4M
FY2021-FY2025
Trend
-32.9%
vs FY2024
Sector context
#46 of 148
Health Care
What the data says
At $526M, Globus Medical's cash & equivalents ranks #46 of 148 in the Health Care sector. Cash & Equivalents has fluctuated over the past 6 years, ranging from $67M in FY2018 to $784M in FY2024.
Based on SEC 10-K filings.
$526M in FY2025.
Improved from $195M to $526M over the past 6 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#46 of 148 in Health CareTop 31% of 148This company $526.2M Sector average $1.2B
▼
-55.3% below sector average
Key checks
Key Insights
- In FY2025, cash & equivalents decreased 32.9% year-over-year.
- Ranks #46 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2024.
- Lowest cash & equivalents in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $526.2M | -32.9% |
| FY2024 | $784.4M | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $195.5M | +192.0% |
| FY2018 | $67.0M | -43.6% |
| FY2017 | $118.8M | +44.4% |
| FY2016 | $82.3M | -8.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026